From 23 to 26 October 2023, our partner IIB will participate in Transcatheter Cardiovascular Therapeutics (TCT 2023) in San Francisco, California. The annual scientific symposium for interventional cardiovascular medicine celebrates its 35th anniversary this year.

Each year, TCT gathers more than 12,000 participants from more than 100 countries, including scientists, researchers and clinicians from around the world, to present and discuss the latest evidence-based research.

The TCT is organised by the Cardiovascular Research Foundation (CRF), one of the world’s leading non-profit organisations specialising in innovation, research and education in interventional cardiology.
The CRF’s mission is to help physicians improve the survival and quality of life of people with cardiovascular disease. For over 30 years, the CRF has helped accelerate medical breakthroughs and educate physicians about the latest treatments for heart disease.

The 12 studies selected for presentation at TCT examine the safety and efficacy of minimally invasive techniques, drugs, technologies and devices that show potential to treat or prevent cardiovascular disease. The latest studies will be featured at press conferences on Tuesday 24 October, Wednesday 25 October and Thursday 26 October.